Annovis Bio, Inc.ANVSNYSE
Loading
Year-over-year operating income growth rate
Percentile
P26
Within normal range
vs 2Y Ago
-1x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -30.55% |
| Q3 2025 | -18.55% |
| Q2 2025 | 0.18% |
| Q1 2025 | 6.71% |
| Q4 2024 | -53.50% |
| Q3 2024 | 43.48% |
| Q2 2024 | 0.60% |
| Q1 2024 | 25.21% |
| Q4 2023 | 29.74% |
| Q3 2023 | -52.29% |
| Q2 2023 | 2.11% |
| Q1 2023 | -27.81% |
| Q4 2022 | -20.29% |
| Q3 2022 | -8.58% |
| Q2 2022 | -213.68% |
| Q1 2022 | 188.74% |
| Q4 2021 | -107.45% |
| Q3 2021 | -12.61% |
| Q2 2021 | 21.52% |
| Q1 2021 | -69.10% |
| Q4 2020 | -19.07% |
| Q3 2020 | 36.95% |
| Q2 2020 | -336.18% |
| Q1 2020 | 33.04% |
| Q4 2019 | -259.90% |
| Q3 2019 | 20.92% |
| Q2 2019 | -63.64% |
| Q1 2019 | -11.31% |
| Q4 2018 | -21.74% |
| Q3 2018 | 36.70% |
| Q2 2018 | -14.74% |
| Q1 2018 | 0.00% |